tert-butyl 6-chloro-3',6'-dihydro-[3,4'-bipyridine]-1'(2'H)-carboxylate

Catalog No. :
ACQZOA401
CAS No. :
1169699-77-7
Molecular Formula :
C15H19ClN2O2
Molecular Weight :
294.78

IUPAC Name:tert-butyl 6-chloro-3',6'-dihydro-[3,4'-bipyridine]-1'(2'H)-carboxylate

tert-butyl 6-chloro-3',6'-dihydro-[3,4'-bipyridine]-1'(2'H)-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$304.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl 6-chloro-3',6'-dihydro-[3,4'-bipyridine]-1'(2'H)-carboxylate
IUPAC Nametert-butyl 6-chloro-3',6'-dihydro-[3,4'-bipyridine]-1'(2'H)-carboxylate
MDL No.MFCD28978570
Molecular FormulaC15H19ClN2O2
Molecular Weight294.78
SMILESCC(C)(C)OC(=O)N1CC=C(C2=CC=C(Cl)N=C2)CC1
InChI KeyQXNHXBMLVJALAE-UHFFFAOYSA-N
Synonym6-Chloro-3',6'-dihydro-2'H-[3,4']bipyridinyl-1'-carboxylic acid tert-butyl ester;tert-butyl 4-(6-chloropyridin-3-yl)-3,6-dihydro-2H-pyridine-1-carboxylate;[3,4'-Bipyridine]-1'(2'H)-carboxylic acid, 6-chloro-3',6'-dihydro-, 1,1-dimethylethyl ester;tert-butyl 6-chloro-3',6'-dihydro-[3,4'-bipyridine]-1'(2'H)-carboxylate
CAS No.1169699-77-7

Synthetic Route by SureRoute

1. ACQZOA401 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDICP462 route compound structure diagram
    ACDICP462138647-49-1 In Stock
  2. Plus
  3. ACEMHZ217 route compound structure diagram
    ACEMHZ217444120-91-6 In Stock
  4. Then
  5. ACQZOA401 route product structure diagram
    ACQZOA4011169699-77-7
Inquiry

2. ACQZOA401 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZAUP421 route compound structure diagram
    ACZAUP421286961-14-6 In Stock
  2. Plus
  3. ACYIHU365 route compound structure diagram
    ACYIHU36553939-30-3 In Stock
  4. Then
  5. ACQZOA401 route product structure diagram
    ACQZOA4011169699-77-7
Inquiry

Comments (0)